INPLASY202160083

Abrocitinib for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials

Keywords: Abrocitinib; atopic dermatitis; efficacy; safety.

Download PDF - 202160083

Review Status: Ongoing